A team of physicists at the Institut Lumière Matière (CNRS/Université Claude Bernard Lyon 1), in collaboration with the Cancer Research Center of Lyon (CNRS/INSERM/ Université Claude Bernard Lyon 1/Centre Léon Bérard/Hospices civils de Lyon), has demonstrated the potential, for oncology, of an imaging technique based only on the physical properties of tumors. It can differentiate populations of malignant cells and monitor how effective an anticancer treatment is. These results, published in Physical Review Letters on January 8, 2019, should help in the design of new therapeutic molecules and in the personalization of treatments.
Despite a good understanding of the biology of cancer, 90% of experimental drugs fail during clinical trials. It is also increasingly suspected that the mechanical properties of tumors influence disease progression, and treatment efficacy. Although we can evaluate tumor elasticity globally, it is more difficult to measure local rigidity deep down and to see whether the core of the tumor resists the penetration of therapeutic liquids. To probe these physical properties, the researchers have used a noncontact imaging technique that does not require the use of contrast agents – therefore that does not disturb tissue function – that exploits natural infinitesimal vibrations of matter.
To recapitulate the behavior of colorectal tumors in vitro, the researchers created organoids, spheres with diameter 0.3 mm formed by the aggregation of tumor cells. They focused a red laser beam onto these objects. The infinitesimal vibrations of the sample, generated by thermal agitation, modify very slightly the color of the light beam that exits the sample. By analyzing this light, a map of the mechanical properties of the model tumors is created: the more rigid the area scanned by the laser, the faster the vibrations and, in a manner comparable to the Doppler effect (the mechanism that makes a siren sound increasingly shrill as it gets closer), the greater the color change.
From organoids composed of two cell lines with different malignancies, the researchers have shown that they could distinguish the two cell types from their mechanical properties. Such information is crucial because it may allow diagnosis from biopsy analysis to be refined and offer better assessment of tumor grade. Local variations in mechanical properties after a drug treatment have also been monitored using this technique: the center of the tumor remains rigid longer than the edge, demonstrating the treatment’s efficacy gradient. So local measurement of mechanical properties could confirm the total destruction of the tumor and help in choosing as low a treatment dose and duration as possible.
This approach allows exploring the impact of mechanical properties on the therapeutic response. It should lead to more predictive in vitro tumor models for testing new therapeutic molecules and for combined therapies, which act for example on tissue rigidity to accelerate the penetration of active molecules in the center of the tumor. It could also provide new indicators to guide clinicians in personalization of therapies.
Learn more: Physics can show us the inside of tumors
The Latest on: Personalized cancer treatment
[google_news title=”” keyword=”personalized cancer treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Personalized cancer treatment
- Focus: Pharma aims to deliver personalized cancer therapies more quicklyon July 24, 2024 at 2:07 am
Big pharmaceutical companies that make personalized blood cancer treatments are working to cut the manufacturing turnaround time by as much as half in coming years, as they try to deliver them sooner ...
- Cancer Research Center Unveils New AI Model For Personalized Careon July 23, 2024 at 11:38 pm
The Hadassah Cancer Research Institute has announced what it says is a significant breakthrough in personalized cancer care.
- Cancer drug custom duty slashed: How will it affect cancer care?on July 23, 2024 at 6:43 am
1) Trastuzumab Deruxtecan is a monoclonal antibody that is used for the treatment of breast and stomach cancers that have HER-2 receptors. These lead to the cancerous tissues growing quickly. Breast ...
- Hadassah Cancer Research Institute (HCRI) Announces Groundbreaking Advance in Personalized Cancer Careon July 23, 2024 at 5:00 am
Hadassah Cancer Research Institute (HCRI), a leading force in advancing cancer treatments, unveils a significant breakthrough in personalized cancer care. This research, published in the esteemed ...
- Budget 2024: These cancer medicines get custom duty exemption – What does this exactly meanson July 23, 2024 at 2:53 am
Exemption from basic customs duty could potentially reduce the price by 10-20 percent, making these treatments more affordable for patients.
- Budget 2024: Three Cancer Treatment Drugs Exempted From Customs Duty; What Does It Mean For the Patients?on July 23, 2024 at 1:09 am
Three cancer treatment medicines will be exempt from basic customs duty to make them more affordable, union Finance Minister Nirmala Sitharaman announced in her Budget 2024 presentation. Also, changes ...
- Known Biomarkers, Better Care: Optimizing a CDS Tool to Guide Personalized Cancer Treatmenton July 22, 2024 at 12:14 pm
Daniel Rubin, PharmD, discusses key takeaways from a study exploring the use. of a clinical decision tool for biomarker documentation.
- Personalized simulations predict blood cancer treatment outcomeson July 17, 2024 at 10:11 am
A new study led by Brighton and Sussex Medical School researchers has developed a groundbreaking way to predict how well treatments work for diffuse large ...
- Personalized simulations predict patient outcomes for blood cancer treatmenton July 16, 2024 at 3:10 pm
A new study unveiled a groundbreaking approach to predicting the effectiveness of treatments for patients with Diffuse Large B-Cell Lymphoma (DLBCL), a common form of blood cancer.
- Immunotherapy Is Changing Cancer Treatment Foreveron July 15, 2024 at 2:01 am
One morning at the end of April 2023, Marcela Maus, a cancer researcher at Mass General in Boston, got a call from her colleague Bryan Choi. “He called me, and he’s like, ‘Oh my God, oh my God, oh my ...
via Bing News